Dutasteride 0,5 mg Teva, zachte capsules

Similar documents
PACKAGE LEAFLET: INFORMATION FOR THE USER. FINASTERIDE 1 MG FILM-COATED TABLETS (finasteride)

Elements for a public summary

Elements for a Public Summary. Overview of disease epidemiology

Package leaflet: Information for the user Finasteride 5 mg Film-coated Tablets Finasteride

PACKAGE LEAFLET: INFORMATION FOR THE USER. Lamisil 1 % cutaneous spray solution Terbinafine hydrochloride

Package Leaflet: Information for the patient. Sustanon 250, 250 mg/ml, solution for injection (testosterone esters)

The capsules are opaque, yellow, oblong soft gelatin capsules filled with an oily and yellowish liquid, without printing.

Natural Hair Transplant Medical Center, Inc Dove Street, Suite #250, Newport Beach, CA Phone

1001 West Broadway, Vancouver, BC V6H 4B1. Topical Finasteride

FINASTERIDE (PROPECIA, PROSCAR) SIDE EFFECT & CONSENT FORM

M0BCore Safety Profile. Pharmaceutical form(s)/strength: 5 mg SE/H/PSUR/0002/006 Date of FAR:

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

Public Assessment Report. Scientific discussion. Dutasteride Regiomedica 0.5 mg capsules, soft (dutasteride) NL/H/2861/001/DC.

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Liquid Medical Oxygen Medicinal gas, cryogenic Package Leaflet: Information for the User

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT 2 QUALITATIVE AND QUANTITATIVE COMPOSITION

PRODUCT INFORMATION TESTOVIRON DEPOT. (testosterone enanthate)

PHYSICIANS CIRCULAR FINASTERIDE PROSCAR. Tablet 5-Alpha Reductase Inhibitor

CSL Behring PACKAGE LEAFLET: INFORMATION FOR THE USER

SAFETY DATA SHEET. Chemical Name: (5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4- azaandrost-1-ene-17-carboxamide.

PACKAGE LEAFLET: INFORMATION FOR THE USER. Exembol Multidose 100 mg/ml concentrate for solution for infusion. Argatroban Monohydrate

Compressed Medical Oxygen Medicinal gas, compressed

PACKAGE LEAFLET: INFORMATION FOR THE USER. Neophyr 225 ppm mol/mol medicinal gas, compressed

Package leaflet: Information for the patient. Danazol Capsules 100 mg Danazol Capsules 200 mg danazol

DUPROST Capsules (Dutasteride)

3. PHARMACEUTICAL FORM Capsules: dull yellow in colour, opaque, oblong soft gelatin capsules with GX CE2 printed on one side in red ink.

Gynaecomastia. Benign breast conditions information provided by Breast Cancer Care

PRODUCT INFORMATION PRIMOTESTON DEPOT. (testosterone enantate)

FINCAR Tablets (Finasteride)

Formally known as anabolic steroids or anabolic-androgenic steroids, but they are sometimes called 'roids', 'gear' or 'juice'.

New Zealand Data Sheet

Dutasteride Avodart Softgel Capsule

Before you use KINERET. When you must not use it. Do not use KINERET if you have. using a medicine known as tumour necrosis factor (TNF) antagonist.

Package leaflet: Information to the user. Medicinsk Lustgas Air Liquide 100%, medicinal gas, liquefied. Nitrous oxide 100% (medicinal laughing gas)

Before you use. When you must not use it

FINASTERIDE PER ALOPECIA ANDROGENETICA FEMMINILE

Package leaflet: Information for the patient

1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING

Product Monograph. Sandoz Dutasteride

WHY IS PREVENTION IMPORTANT?

STAYING ON TRACK WITH CINRYZE THERAPY

ARE FINASTERIDE SIDE EFFECTS PERMANENT

Package leaflet: Information to the user. Kalinox 50 %/50 % medicinal gas, compressed. Nitrous oxide / Oxygen

AVODART (dutasteride) Soft Gelatin Capsules

Secrets of Abang Sado : Effects of testosterone therapy. Azraai Nasruddin

SUMMARY OF PRODUCT CHARACTERISTICS

PACKAGE LEAFLET: INFORMATION FOR THE USER. Medical Oxygen/Carbon Dioxide Mixtures Oxygen, Carbon Dioxide, Medicinal gas, compressed

Safety data sheet MICRO AIR Revision date : 2009/05/20 Page: 1/6

Androgens and Anabolic Steroids Prior Authorization with Quantity Limit - Through Preferred Topical Androgen Agent

FULL PRESCRIBING INFORMATION

MATERIAL SAFETY DATA SHEET

Are Steroids Worth the Risk?

SAFETY DATA SHEET. This material is hazardous according to criteria of Occupational Safety and Health (OSHA) HAZARDOUS SUBSTANCE.

DUTASTERIDE capsules, for oral use Initial U.S. Approval: 2001

SUMMARY OF PRODUCT CHARACTERISTICS

Version 4, 02/2016 SUMMARY OF PRODUCT CHARACTERISTICS, LABELLING AND PACKAGE LEAFLET. common-spc Pg. 1

Health Products Regulatory Authority

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET

Androgenes and Antiandrogenes

MATERIAL SAFETY DATA SHEET Page 1 of 5.

PREPARATION AND SELF-ADMINISTRATION INSTRUCTIONS FOR PATIENTS

What do these athletes have in common?

SAFETY DATA SHEET Page 1 of 5 Product Name: COPACAPS 5g, 10g, 20g, 30g Reviewed on: 13 September 2007

Affirming Care of the Transgender Patient

AVODART (dutasteride) Soft Gelatin Capsules

Safety data sheet GLENIUM 3030 NS Revision date : 2009/03/30 Page: 1/5

Cefixime - MATERIAL SAFETY DATA SHEET

Safety data sheet NAVITAS 33 Revision date : 2009/03/26 Page: 1/5

PRODUCT INFORMATION CF 3

TEV-TROPIN [somatropin (rdna origin) for injection] 5 mg & 10 mg

SOYA LECITHIN. Emulsifier; dispersant; antioxidant; food additive. Level 8, 1 Nicholson Street East Melbourne Victoria 3002 Australia

Safety Data Sheet Lyden Oil Company

SUMMARY OF PRODUCT CHARACTERISTICS 2 QUALITATIVE AND QUANTITATIVE COMPOSITION

FORMULA 2000 PLUS COMPONENT

FACTSHEET F36 UNDERSTANDING YOUR HOME OXYGEN THERAPY. Why do I need oxygen therapy at home? How will oxygen therapy help me?

FERRIC SULPHATE SOLID. Coagulant in water treatment applications. Level 8, 1 Nicholson Street East Melbourne Victoria 3002 Australia

SAFETY DATA SHEET. NOW Health Group 395 Glen Ellyn Rd Bloomingdale, IL US ChemTel

PREPARATION AND SELF-ADMINISTRATION INSTRUCTIONS FOR PATIENTS

Safety Data Sheet MasterPozzolith 210 also POZZOLITH 210 Revision date : 2013/12/17 Page: 1/6

Safety and Tolerability of the Dual 5a-Reductase Inhibitor Dutasteride in thetreatment of Benign Prostatic Hyperplasia

Safety data sheet RHEOPEL PLUS MORTAR ADMIX Revision date : 2009/04/02 Page: 1/6

SECTION 1: Identification of the substance/mixture and of the company/undertaking N : DANGEROUS FOR THE ENVIRONMENT 1 / 8

PDF created with pdffactory Pro trial version SAFETY DATA SHEET

Safety Data Sheet According to NOHSC:2011(2003)

Safety Data Sheet MasterProtect EL 850 TB ultradeep also SILFLEX TB ULTRA DEEP Revision date : 2011/06/10 Page: 1/6

1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING. : ASTRAZENECA P.O. Box Wilmington, DE USA

Issues. What is a low testosterone? Who needs testosterone therapy? Benefits/adverse effects of testosterone replacement Treatment options

Schistosomiasis / Bilharzia

International Nutrition, Inc. Safety Data Sheet

Material Safety Data Sheet

Safety Data Sheet According to NOHSC:2011(2003)

Safety Data Sheet MasterLife CI 30 also RHEOCRETE CNI Revision date : 2012/02/29 Page: 1/5

TREATMENT GUIDE. Your treatment. Your questions answered.

MATERIAL SAFETY DATA SHEET

Pestell Minerals & Ingredients Inc. Safety Data Sheet

1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING

This is an English translation of the original Chinese instruction leaflet generated by Google Translate. No amendments were made.

Transcription:

BIJSLUITER: INFORMATIE VOOR DE GEBRUIKER Dutasteride 0,5 mg Teva, zachte capsules Dutasteride Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet 1. What [Product name] is and what it is used for 2. What you need to know before you take [Product name] 3. How to take [Product name] 4. Possible side effects 5. How to store [Product name] 6. Contents of the pack and other information 1. What [Product name] is and what it is used for The active ingredient is dutasteride. It belongs to a group of medicines called 5-alpha reductase inhibitors. [Product name] is used to treat men with an enlarged prostate (benign prostatic hyperplasia) - a non-cancerous growth of the prostate gland, caused by producing too much of a hormone called dihydrotestosterone. As the prostate grows, it can lead to urinary problems, such as difficulty in passing urine and a need to go to the toilet frequently. It can also cause the flow of the urine to be slower and less forceful. If left untreated, there is a risk that your urine flow will be completely blocked (acute urinary retention). This requires immediate medical treatment. In some situations surgery is necessary to remove or reduce the size of the prostate gland. Dutasteride lowers the production of dihydrotestosterone, which helps to shrink the prostate and relieve the symptoms. This will reduce the risk of acute urinary retention and the need for surgery. [Product name] may also be used with another medicine called tamsulosin (used to treat the symptoms of an enlarged prostate). 2. What you need to know before you take [Product name] Do NOT take [Product name]: - if you are allergic to dutasteride, other 5-alpha reductase inhibitors, soya, peanuts or to any of the other ingredients of this medicine (listed in section 6). - if you have a severe liver disease. - if you are a child or adolescent. Tell your doctor if you think any of these apply to you. This medicine is for men only. It must not be taken by women, children or adolescents. Warnings and precautions Talk to your doctor or pharmacist before taking [Product name]. 1

- In some clinical studies, more patients taking dutasteride and another medicine called an alpha blocker, like tamsulosin, experienced heart failure than patients taking only dutasteride or only an alpha blocker. Heart failure means your heart does not pump blood as well as it should. - Make sure your doctor knows about any liver problems. If you have had any illness affecting your liver, you may need some additional check-ups while you are taking [Product name]. - Women, children and adolescents must not handle leaking [Product name] capsules, because the active ingredient can be absorbed through the skin. Wash the affected area immediately with soap and water if there is any contact with the skin. - Use a condom during sexual intercourse. Dutasteride has been found in the semen of men taking [Product name]. If your partner is or may be pregnant, you must avoid exposing her to your semen as dutasteride may affect the normal development of a male baby. Dutasteride has been shown to decrease sperm count, semen volume and sperm motility. This could reduce your fertility. - [Product name] affects a blood test for PSA (prostate-specific antigen), which is sometimes used to detect prostate cancer. Your doctor should be aware of this effect and can still use the test to detect prostate cancer. If you are having a blood test for PSA, tell your doctor that you are taking [Product name]. Men taking dutasteride should have their PSA tested regularly. In a clinical study of men at increased risk of prostate cancer, men taking dutasteride had a serious form of prostate cancer more often than men who did not take dutasteride. The effect of dutasteride on this serious form of prostate cancer is not clear. - [Product name] may cause breast enlargement and tenderness. If this becomes troublesome or if you notice breast lumps or nipple discharge you should talk to your doctor about these changes as these may be signs of a serious condition, such as breast cancer. Contact your doctor or pharmacist if you have any questions about taking [Product name]. Other medicines and [Product name] Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. Some medicines can react with [Product name] and may make it more likely that you will have side effects. These medicines include: - Verapamil or diltiazem (for high blood pressure), - Ritonavir or indinavir (for HIV), - Itraconazole or ketaconazole (for fungal infections), - Nefazodone (an antidepressant), - Alpha blockers (for enlarged prostate or high blood pressure). Tell your doctor if you are taking any of these medicines. Your dose of [Product name] may need to be reduced. [Product name] with food and drink [Product name] can be taken with or without food. Pregnancy, breast-feeding and fertility Women must not take [Product name]. Women who are pregnant (or may be pregnant) must not handle leaking capsules. Dutasteride is absorbed through the skin and can affect the normal development of a male baby. This is a particular risk in the first 16 weeks of pregnancy. Contact your doctor for advice if a pregnant woman has come into contact with dutasteride. Use a condom during sexual intercourse. Dutasteride has been found in the semen of men taking [Product name]. If your partner is or may be pregnant, you must avoid exposing her to your semen. 2

Dutasteride has been shown to reduce sperm count, semen volume and sperm movement. Therefore male fertility may be reduced. Driving and using machines [Product name] is unlikely to affect your ability to drive or operate machinery. [Product name] contains soya lecithin This medicine contains lecithin from soya, which may contain soya oil. If you are allergic to peanuts or soya, do not use this medicinal product. 3. How to take [Product name] Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. If you do not take it regularly the monitoring of your PSA levels may be affected. How much to take: The recommended dose is one capsule (0.5 mg) taken once a day. Swallow the capsules whole with water. Do not chew or break open the capsule. Contact with the contents of the capsules may make your mouth or throat sore. [Product name] is a long term treatment. Some men notice an early improvement in their symptoms. However, others may need to take [Product name] for 6 months or more before it begins to have an effect. Keep taking [Product name] for as long as your doctor tells you. If you take more [Product name] than you should Contact your doctor or pharmacist for advice if you take too many [Product name] capsules. If you forget to take [Product name] Do not take a double dose to make up for a forgotten dose. Just take your next dose at the usual time. If you stop taking [Product name] Do not stop taking [Product name] without talking to your doctor first. It may take up to 6 months or more for you to notice an effect. If you have any further questions on the use of this medicine, ask your doctor or pharmacist. 4. Possible side effects Like all medicines, this medicine can cause side effects, although not everybody gets them. Allergic reaction The signs of allergic reactions can include: - Skin rash (which can be itchy), - Hives (like a nettle rash), - Swelling of the eyelids, face, lips, arms or legs. Contact your doctor immediately if you get any of these symptoms, and stop using [Product name]. Common side effects May affect up to 1 in 10 men taking [Product name]: - Not able to achieve or maintain an erection (impotence)*, *this may continue after you stop taking [Product Name]. - Decreased sex drive (libido)*, * this may continue after you stop taking [Product Name]. - Difficulty with ejaculation*, * this may continue after you stop taking [Product Name]. - Breast enlargement or tenderness (gynecomastia), - Dizziness when taken with tamsulosin. 3

Uncommon side effects May affect up to 1 in 100 men taking [Product name]: - Heart failure (heart becomes less efficient at pumping blood around the body. You may have symptoms such as shortness of breath, extreme tiredness and swelling in your ankles and legs), - Hair loss (usually from the body) or hair growth. Not known side effects Frequency cannot be estimated from the available data: - Depressed mood, - Pain and swelling in your testicles. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. Reporting of side effects If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine. 5. How to store [Product name] Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the carton or the foil blister, after EXP. The expiry date refers to the last day of that month. Do not store above 30 C. Store in the original package in order to protect from moisture. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment. 6. Contents of the pack and other information What [Product name] contains - The active substance is dutasteride. - Each soft capsule contains 0.5 mg dutasteride. - The other ingredients are: - inside the capsule: glycerol monocaprylocaprate (type I), butylhydroxytoluene (E321). - capsule shell: gelatin, glycerol, titanium dioxide (E171), iron oxide yellow (E172), triglycerides (medium chain), lecithin (may contain soya oil) (E322) and purified water. What [Product name] looks like and contents of the pack [Product name] soft capsules are size 6, oblong, opaque and yellow, soft gelatin capsules containing an oily and yellowish liquid. They are available in packs of 10, 30, 60 and 90 capsules. Not all pack sizes may be marketed. Soft capsules dimensions are: 19 ± 0.8 mm x 6.9 ± 0.4 mm. Houder van de vergunning voor het in de handel brengen en fabrikant Houder van de vergunning voor het in de handel brengen Teva Nederland B.V. Swensweg 5 4

2031 GA Haarlem Nederland Fabrikanten Cyndea Pharma S.L. Polígono Industrial Emiliano Revilla Sanz, Avenida de Ágreda, 31 42110 Olvega Soria Galenicum Health S.L. Avda. Cornellá 144, 7º-1a, Edificio Lekla 08950 Esplugues de Llobregat Pharmadox Healthcare Ltd KW20A Kordin Industrial Park PLA 3000 Paola Malta Merckle GmbH Ludwig-Merckle-Strasse 3 89143 Blaubeuren Duitsland In het register ingeschreven onder RVG 118176 Dit geneesmiddel is geregistreerd in lidstaten van de EEA onder de volgende namen: Denemarken Dutasterid Teva B.V. Estland Teduva Frankrijk Dutastéride Teva France 0.5 mg capsule molle Ierland Dutasteride 0.5 mg Soft Capsules Italië Dutasteride Teva Italia Letland Teduva 0,5 mg mīkstās kapsulas Litouwen Teduva 0,5 mg minkštosios kapsulės Malta Dutasteride 0.5 mg Soft Capsules Nederland Dutasteride 0,5 mg Teva, zachte capsules Portugal Dutasterida Zidrium Slovenië Dutrex 0,5 mg mehke kapsule Dutasterida Tevagen 0,5 mg cápsulas blandas EFG Verenigd Koninkrijk Dutasteride 0.5 mg Capsules, Soft Deze bijsluiter is voor het laatst goedgekeurd in januari 2017 5